Cowen Prime Advisors’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | $10.1K | Hold |
100
| – | – | ﹤0.01% | 167 |
|
2023
Q1 | $10K | Hold |
100
| – | – | ﹤0.01% | 168 |
|
2022
Q4 | $9K | Hold |
100
| – | – | ﹤0.01% | 166 |
|
2022
Q3 | $8K | Hold |
100
| – | – | ﹤0.01% | 150 |
|
2022
Q2 | $8K | Hold |
100
| – | – | ﹤0.01% | 158 |
|
2022
Q1 | $9K | Hold |
100
| – | – | ﹤0.01% | 158 |
|
2021
Q4 | $9K | Hold |
100
| – | – | ﹤0.01% | 153 |
|
2021
Q3 | $8K | Hold |
100
| – | – | ﹤0.01% | 152 |
|
2021
Q2 | $9K | Hold |
100
| – | – | ﹤0.01% | 149 |
|
2021
Q1 | $9K | Hold |
100
| – | – | ﹤0.01% | 151 |
|
2020
Q4 | $9K | Hold |
100
| – | – | ﹤0.01% | 153 |
|
2020
Q3 | $9K | Hold |
100
| – | – | ﹤0.01% | 154 |
|
2020
Q2 | $8K | Hold |
100
| – | – | ﹤0.01% | 158 |
|
2020
Q1 | $8K | Hold |
100
| – | – | ﹤0.01% | 161 |
|
2019
Q4 | $9K | Hold |
100
| – | – | ﹤0.01% | 151 |
|
2019
Q3 | $9K | Hold |
100
| – | – | ﹤0.01% | 142 |
|
2019
Q2 | $9K | Sell |
100
-12
| -11% | -$1.08K | ﹤0.01% | 149 |
|
2019
Q1 | $10K | Hold |
112
| – | – | 0.01% | 148 |
|
2018
Q4 | $9K | Hold |
112
| – | – | 0.01% | 155 |
|
2018
Q3 | $9K | Hold |
112
| – | – | ﹤0.01% | 176 |
|
2018
Q2 | $8K | Hold |
112
| – | – | ﹤0.01% | 184 |
|
2018
Q1 | $8K | Hold |
112
| – | – | ﹤0.01% | 178 |
|
2017
Q4 | $8K | Hold |
112
| – | – | ﹤0.01% | 171 |
|
2017
Q3 | $9K | Hold |
112
| – | – | ﹤0.01% | 164 |
|
2017
Q2 | $8K | Hold |
112
| – | – | ﹤0.01% | 168 |
|
2017
Q1 | $7K | Buy |
+112
| New | +$7K | ﹤0.01% | 170 |
|